Correlation Between Faron Pharmaceuticals and Indivior PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Faron Pharmaceuticals and Indivior PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Faron Pharmaceuticals and Indivior PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Faron Pharmaceuticals Oy and Indivior PLC, you can compare the effects of market volatilities on Faron Pharmaceuticals and Indivior PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Faron Pharmaceuticals with a short position of Indivior PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Faron Pharmaceuticals and Indivior PLC.

Diversification Opportunities for Faron Pharmaceuticals and Indivior PLC

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Faron and Indivior is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Faron Pharmaceuticals Oy and Indivior PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Indivior PLC and Faron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Faron Pharmaceuticals Oy are associated (or correlated) with Indivior PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Indivior PLC has no effect on the direction of Faron Pharmaceuticals i.e., Faron Pharmaceuticals and Indivior PLC go up and down completely randomly.

Pair Corralation between Faron Pharmaceuticals and Indivior PLC

Assuming the 90 days trading horizon Faron Pharmaceuticals Oy is expected to under-perform the Indivior PLC. In addition to that, Faron Pharmaceuticals is 1.58 times more volatile than Indivior PLC. It trades about -0.01 of its total potential returns per unit of risk. Indivior PLC is currently generating about 0.27 per unit of volatility. If you would invest  69,100  in Indivior PLC on September 24, 2024 and sell it today you would earn a total of  22,350  from holding Indivior PLC or generate 32.34% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Faron Pharmaceuticals Oy  vs.  Indivior PLC

 Performance 
       Timeline  
Faron Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Faron Pharmaceuticals Oy has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Indivior PLC 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Indivior PLC are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Indivior PLC unveiled solid returns over the last few months and may actually be approaching a breakup point.

Faron Pharmaceuticals and Indivior PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Faron Pharmaceuticals and Indivior PLC

The main advantage of trading using opposite Faron Pharmaceuticals and Indivior PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Faron Pharmaceuticals position performs unexpectedly, Indivior PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indivior PLC will offset losses from the drop in Indivior PLC's long position.
The idea behind Faron Pharmaceuticals Oy and Indivior PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity